GW842166   Click here for help

GtoPdb Ligand ID: 12753

Synonyms: compound 35 [PMID: 17477516] | GW8-42166 | GW8-42166X | GW842166X
Compound class: Synthetic organic
Comment: GW842166 is a synthetic, selective cannabinoid CB2 receptor agonist [2]. It was developed for potential analgesic action, in particular for the treatment of acute inflammatory pain.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 6
Hydrogen bond donors 2
Rotatable bonds 7
Topological polar surface area 75.08
Molecular weight 449.25
XLogP 1.82
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES C1=C(C=C(C(=C1)NC2=NC(=C(C=N2)C(=O)NCC3CCOCC3)C(F)(F)F)Cl)Cl
Isomeric SMILES ClC1=C(NC2=NC=C(C(=N2)C(F)(F)F)C(=O)NCC3CCOCC3)C=CC(=C1)Cl
InChI InChI=1S/C18H17Cl2F3N4O2/c19-11-1-2-14(13(20)7-11)26-17-25-9-12(15(27-17)18(21,22)23)16(28)24-8-10-3-5-29-6-4-10/h1-2,7,9-10H,3-6,8H2,(H,24,28)(H,25,26,27)
InChI Key TWQYWUXBZHPIIV-UHFFFAOYSA-N
No information available.
Summary of Clinical Use Click here for help
GW842166 was advanced to clinical trial to evaluate efficacy as a treatment for osteoarthritis pain. It appears that development has been discontinued.
Clinical Trials
Clinical Trial ID Title Type Source Comment References
NCT00447486 A Study of GW842166 in Adults With Osteoarthritis Pain Phase 2 Interventional GlaxoSmithKline
NCT00444769 Dental Pain 3rd Molar Tooth Extraction GW842166 Phase 2 Interventional GlaxoSmithKline
NCT00479427 A Study Of The Effects Of CB2 Compound Of GW842166 In Patients With Osteoarthritis Phase 2 Interventional GlaxoSmithKline